Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticusR0052 andBifidobacterium longumR0175) in rats and human subjects
Top Cited Papers
- 26 October 2010
- journal article
- research article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 105 (5), 755-764
- https://doi.org/10.1017/s0007114510004319
Abstract
In a previous clinical study, a probiotic formulation (PF) consisting ofLactobacillus helveticusR0052 andBifidobacterium longumR0175 (PF) decreased stress-induced gastrointestinal discomfort. Emerging evidence of a role for gut microbiota on central nervous system functions therefore suggests that oral intake of probiotics may have beneficial consequences on mood and psychological distress. The aim of the present study was to investigate the anxiolytic-like activity of PF in rats, and its possible effects on anxiety, depression, stress and coping strategies in healthy human volunteers. In the preclinical study, rats were daily administered PF for 2 weeks and subsequently tested in the conditioned defensive burying test, a screening model for anti-anxiety agents. In the clinical trial, volunteers participated in a double-blind, placebo-controlled, randomised parallel group study with PF administered for 30 d and assessed with the Hopkins Symptom Checklist (HSCL-90), the Hospital Anxiety and Depression Scale (HADS), the Perceived Stress Scale, the Coping Checklist (CCL) and 24 h urinary free cortisol (UFC). Daily subchronic administration of PF significantly reduced anxiety-like behaviour in rats (P < 0·05) and alleviated psychological distress in volunteers, as measured particularly by the HSCL-90 scale (global severity index,P < 0·05; somatisation,P < 0·05; depression,P < 0·05; and anger–hostility,P < 0·05), the HADS (HADS global score,P < 0·05; and HADS-anxiety,P < 0·06), and by the CCL (problem solving,P < 0·05) and the UFC level (P < 0·05).L. helveticusR0052 andB. longumR0175 taken in combination display anxiolytic-like activity in rats and beneficial psychological effects in healthy human volunteers.Keywords
This publication has 73 references indexed in Scilit:
- A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndromeGut Pathogens, 2009
- Lactobacillus reuteri–induced Regulatory T cells Protect against an Allergic Airway Response in MiceAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: Implications for an animal model of autismNeuropharmacology, 2008
- Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: Possible anatomical substrates for viscerosensory modulation of exploratory behaviorBrain, Behavior, and Immunity, 2008
- Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separationGut, 2007
- Identification of an immune-responsive mesolimbocortical serotonergic system: Potential role in regulation of emotional behaviorNeuroscience, 2007
- Anxiety and aggression associated with the fermentation of carbohydrates in the hindgut of ratsPhysiology & Behavior, 2004
- Paroxetine for the Prevention of Depression Induced by High-Dose Interferon AlfaThe New England Journal of Medicine, 2001
- Gapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Research, 1997
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983